Press release
Rising prevalence of ischemia stroke cases in Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market
“Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market" research report published by Market Data Forecast estimates that the market is growing with a CAGR of 7.9% to reach USD 507.758 million by 2021, from USD 356.726 million in 2016, which amounts to a cumulative growth of USD 151.03 million.Acute ischemic strokes imply the loss of brain function in certain parts created by the lack of blood supply to the brain. This is usually caused by atherosclerosis plaques narrowing of blood vessels, blocking blood vessels, or blood clots closing off blood supply to or from arteries feeding the brain.
Technological advancements in surgical devices coupled with growing prevalence of acute ischemia stroke cases collectively accentuates the Asia-Pacific demand of surgical procedures in acute stroke treatment. The most common cause of acute ischemic strokes is the formation of blood clots in the arteries to the brain and formation of atherosclerosis plaques that narrow or block blood vessels.
Free Sample for report: http://www.marketdataforecast.com/market-reports/asia-pacific-acute-ischemic-stroke-diagnosis-market-268/request-sample
The report also presents detailed analysis of multitude of factors affecting Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market bearing either positive or negative outcomes. Some of those factors are
• Technological advancements in surgical procedures along with rising aging population
• Increasing demand for minimally invasive procedures
• Growth in healthcare spending
• High population base and growing incidence of cardiovascular
• Excessive usage of medication for the treatment of ischemic stroke
• High cost of surgical procedures.
Customized report URL: http://www.marketdataforecast.com/market-reports/asia-pacific-acute-ischemic-stroke-diagnosis-market-268/customize-report
For granular level understanding, the Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market is segmented based on Diagnostic type and Surgery type each being provided with Market Size Estimations and Y-o-Y Forecasts. Diagnostic type is further sub-segmented into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Cerebral angiography and nuclear imaging. Based on Surgery Type, the market is segmented into Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy.
Inquire Before Buying: http://www.marketdataforecast.com/market-reports/asia-pacific-acute-ischemic-stroke-diagnosis-market-268/inquire
On a geographical perspective Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market is analyzed under various regions namely China, India, Japan and Australia. Asia-Pacific is the most promising market for acute ischemic stroke diagnosis owing to increasing number of patients with cardiac related problems such as ischemic stroke. Manufacturers across various geographies are expanding their operations in Asia-Pacific region as these regions hold immense potential for the market growth.
Buy Now: https://www.marketdataforecast.com/cart/buy-now/asia-pacific-acute-ischemic-stroke-diagnosis-market-268
Some of the major companies covered in the report are Abbott Laboratories, Covidien plc., Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Stryker Corporation (Concentric Medical, Inc.) and Hitachi, Ltd.
Request Discount: http://www.marketdataforecast.com/market-reports/asia-pacific-acute-ischemic-stroke-diagnosis-market-268/request-discount
The Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of Diagnostic type and Surgery type with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Acute Ischemic Stroke Diagnosis and Treatment Market:
Companion Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/
In-vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-in-vitro-diagnostics-market-146/
Preclinical In-vivo Imaging Market: http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
Contact:
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Jubilee Gardens,
Hyderabad, India.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising prevalence of ischemia stroke cases in Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market here
News-ID: 534459 • Views: …
More Releases from Market Data Forecast

Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024.
The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations…

Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029.
It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively…

End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period.
Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user…

Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period.
Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…